Directors

Aarti Veeravalli Sevilimedu

Director/Designated Partner
over 11 years ago

Pushkar Kulkarni

Director/Designated Partner
over 12 years ago

Patents

Magnetic Nanoparticle Formulations For Targeted Delivery Of Drugs To Lungs For Treatment Of Pulmonary Diseases

Abstract Cytotoxic drugs such as Irinotecan are used as first line therapy for a variety of cancers. Cytotoxic drugs are very effective at killing the tumour cells but have an undesirable side effect because they also destroy normal healthy cells. Secondly, even if the drugs enter a tissue they may be transported o...

Documents

Form STK-2-07082021-signed

Form MGT-14-16042019_signed

Copy(s) of resolution(s) along with copy of explanatory statement under section 173-16042019

-16042019

List of share holders, debenture holders;-12102018

Directors report as per section 134(3)-12102018

Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-12102018

Form AOC-4-12102018_signed

Form MGT-7-12102018_signed

List of share holders, debenture holders;-10082017

Directors report as per section 134(3)-10082017

Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-10082017

Form AOC-4-10082017_signed

Form MGT-7-10082017_signed

Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-26092016

Directors report as per section 134(3)-26092016

List of share holders, debenture holders;-26092016

Form MGT-7-26092016_signed

Form AOC-4-26092016_signed

Form MGT-7-121015.OCT

Form AOC-4-101015.OCT

Form23AC-271114 for the FY ending on-310314.OCT

FormSchV-271114 for the FY ending on-310314.OCT

Form MGT-14-261114.OCT

Copy of resolution-251114.PDF

-231114.OCT

Form DIR-11-241014.OCT

Optional Attachment 1-211014.PDF

Form 23B for period 290813 to 310314-130913.OCT